BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26762238)

  • 1. Effect of levosimendan therapy on myocardial infarct size and left ventricular function after acute coronary occlusion.
    Tarkia M; Stark C; Haavisto M; Kentala R; Vähäsilta T; Savunen T; Strandberg M; Saunavaara V; Tolvanen T; Teräs M; Pietilä M; Nyman L; Duvall E; Saukko P; Levijoki J; Roivainen A; Saraste A; Knuuti J
    Heart; 2016 Mar; 102(6):465-71. PubMed ID: 26762238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia.
    Sonntag S; Sundberg S; Lehtonen LA; Kleber FX
    J Am Coll Cardiol; 2004 Jun; 43(12):2177-82. PubMed ID: 15193677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
    Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
    Oner E; Erturk M; Birant A; Kurtar Mansıroglu A; Akturk IF; Karakurt H; Yalcin AA; Uzun F; Somuncu MU; Yildirim A
    Cardiol J; 2015; 22(1):87-93. PubMed ID: 24846511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 6-month follow-up of intermittent levosimendan administration effect on systolic function, specific activity questionnaire, and arrhythmia in advanced heart failure.
    Mavrogeni S; Giamouzis G; Papadopoulou E; Thomopoulou S; Dritsas A; Athanasopoulos G; Adreanides E; Vassiliadis I; Spargias K; Panagiotakos D; Cokkinos DV
    J Card Fail; 2007 Sep; 13(7):556-9. PubMed ID: 17826646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of levosimendan on left ventricular relaxation and early filling at maintained preload and afterload conditions after aortic valve replacement for aortic stenosis.
    Jörgensen K; Bech-Hanssen O; Houltz E; Ricksten SE
    Circulation; 2008 Feb; 117(8):1075-81. PubMed ID: 18268152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study.
    Husebye T; Eritsland J; Müller C; Sandvik L; Arnesen H; Seljeflot I; Mangschau A; Bjørnerheim R; Andersen GØ
    Eur J Heart Fail; 2013 May; 15(5):565-72. PubMed ID: 23288914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren.
    Shah AM; Shin SH; Takeuchi M; Skali H; Desai AS; Køber L; Maggioni AP; Rouleau JL; Kelly RY; Hester A; Keefe D; McMurray JJ; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2012 Feb; 14(2):185-92. PubMed ID: 21965526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of cardiac function and remodeling induced by myocardial infarction in rats are attenuated by the nonpeptide angiotensin-(1-7) analog AVE 0991.
    Zeng WT; Chen WY; Leng XY; Tang LL; Sun XT; Li CL; Dai G
    Cardiovasc Ther; 2012 Jun; 30(3):152-61. PubMed ID: 21167013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-response study of levosimendan in a porcine model of acute ischaemic heart failure.
    Kolseth SM; Wahba A; Kirkeby-Garstad I; Aro S; Nordgaard H; Høydal M; Rognmo Ø; Nordhaug D
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):1377-83. PubMed ID: 22219475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Combined Milrinone and Levosimendan Treatment on Systolic and Diastolic Function During Postischemic Myocardial Dysfunction in a Porcine Model.
    Axelsson B; Häggmark S; Svenmarker S; Johansson G; Gupta A; Tydén H; Wouters P; Haney M
    J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):495-503. PubMed ID: 26837238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
    De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
    Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of levosimendan on cardiac gene expression profile and post-infarct cardiac remodelling in diabetic Goto-Kakizaki rats.
    Vahtola E; Storvik M; Louhelainen M; Merasto S; Lakkisto P; Lakkisto J; Tikkanen I; Kaheinen P; Levijoki J; Mervaala E
    Basic Clin Pharmacol Toxicol; 2011 Nov; 109(5):387-97. PubMed ID: 21699655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levosimendan in cardiac failure after subarachnoid hemorrhage.
    Busani S; Rinaldi L; Severino C; Cobelli M; Pasetto A; Girardis M
    J Trauma; 2010 May; 68(5):E108-10. PubMed ID: 20453750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing preclinical models of ischemic heart failure: differences between LAD and LCx infarctions.
    Ishikawa K; Aguero J; Tilemann L; Ladage D; Hammoudi N; Kawase Y; Santos-Gallego CG; Fish K; Levine RA; Hajjar RJ
    Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1478-86. PubMed ID: 25217654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Intracoronary Metformin on Myocardial Infarct Size in Swine.
    Techiryan G; Weil BR; Palka BA; Canty JM
    Circ Res; 2018 Sep; 123(8):986-995. PubMed ID: 30355033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
    Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
    Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of levosimendan on myocardial infarct size and hemodynamics in a closed-chest porcine ischemia-reperfusion model.
    Busk M; Maeng M; Kristensen J; Berg JS; Mortensen UM; Nielsen TT; Nielsen-Kudsk JE
    Cardiovasc Drugs Ther; 2006 Oct; 20(5):335-42. PubMed ID: 17122904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of levosimendan on restrictive left ventricular filling in severe heart failure: a combined hemodynamic and Doppler echocardiographic study.
    Dernellis J; Panaretou M
    Chest; 2005 Oct; 128(4):2633-9. PubMed ID: 16236936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of early coronary reperfusion on left ventricular remodeling and systolic function in patients with acute myocardial infarction.
    Yang Y; Gao R; Tian J; Xu Y; Chen Z; Yao K; Chen J
    Chin Med J (Engl); 1998 Feb; 111(2):142-6. PubMed ID: 10374375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.